Answers are grounded in this paper and cite their sources.
Innovative framework for adaptive treatment allocation using imaging data enhances patient outcomes, indicating improved trial efficiency.
Motivated by a recent trial using MRI scans to compare treatments for nasopharyngeal carcinoma, we recognize that imaging predictors can significantly improve treatment selection. However, such models are built retrospectively under equal randomization, not integrated in real time to inform adaptive treatment allocation. This article proposes a covariate‐adjusted response‐adaptive (CARA) randomization framework that prospectively incorporates imaging data. Using supervised functional principal component analysis (sFPCA), we extract features from patient images to enable adaptive randomization based on imaging covariates. By dynamically adjusting randomization probabilities to favour more effective treatments as data accumulate, our method aims to enhance patient outcomes within the trial, supporting an ethical trial design. Simulations show that CARA with imaging covariates allocates more patients to better treatments while maintaining good statistical power and accuracy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: